These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1997858)

  • 21. Cytoprotective agents for anthracyclines.
    Dorr RT
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):23-34. PubMed ID: 8783663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Scavenging of probimane on semiquinone free radical formation by doxorubicin in rat heart].
    Zhang Y; Zhang TM; Zhao BL; Han JK; Chen WC; Xin WJ
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):20-3. PubMed ID: 1950578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adriamycin: cardiotoxicity].
    Gamna G; Lovisetto P; Pochnettino G; Biarese V
    Boll Soc Ital Cardiol; 1974; 19(7):633-70. PubMed ID: 4464961
    [No Abstract]   [Full Text] [Related]  

  • 24. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
    Platel D; Bonoron-Adèle S; Dix RK; Robert J
    Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 26. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Ferrans VJ
    Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity.
    Wojnowski L; Kulle B; Schirmer M; Schlüter G; Schmidt A; Rosenberger A; Vonhof S; Bickeböller H; Toliat MR; Suk EK; Tzvetkov M; Kruger A; Seifert S; Kloess M; Hahn H; Loeffler M; Nürnberg P; Pfreundschuh M; Trümper L; Brockmöller J; Hasenfuss G
    Circulation; 2005 Dec; 112(24):3754-62. PubMed ID: 16330681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 29. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
    Olson LE; Bedja D; Alvey SJ; Cardounel AJ; Gabrielson KL; Reeves RH
    Cancer Res; 2003 Oct; 63(20):6602-6. PubMed ID: 14583452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
    Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
    Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin cardiotoxicity: growing importance.
    Orhan B
    J Clin Oncol; 1999 Jul; 17(7):2294-6. PubMed ID: 10561289
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution of electron microscopy to the study of anthracycline cardiotoxicity].
    Anjo A; Levi F; Reynes M
    Bull Assoc Anat (Nancy); 1991 Jun; 75(229):7-9. PubMed ID: 1777720
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dexrazoxane. Current status and prospectives of cardiotoxicity of chemotherapy].
    Lopez M
    Clin Ter; 1999; 150(1):37-49. PubMed ID: 10367544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiomyopathy induced by cytostatic drugs].
    Bühner R
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1097. PubMed ID: 408660
    [No Abstract]   [Full Text] [Related]  

  • 36. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction.
    Chicco AJ; Schneider CM; Hayward R
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):182-9. PubMed ID: 16495754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast].
    Ferrero JM; Magné N; Foa C; Largillier R; Namer M
    Bull Cancer; 2003 Mar; 90(3):219-26. PubMed ID: 12801824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does catalase play a role in Adriamycin induced cardiotoxicity?
    D'Alessandro N; Dusonchet L; Crosta L; Crescimanno M; Rausa L
    Pharmacol Res Commun; 1981 Feb; 13(2):205-11. PubMed ID: 7220578
    [No Abstract]   [Full Text] [Related]  

  • 39. Utility of non-invasive instantaneous screening test for drug-induced cardiac damage.
    Hrushesky WJ
    J Clin Oncol; 1985 Oct; 3(10):1438-9. PubMed ID: 4045533
    [No Abstract]   [Full Text] [Related]  

  • 40. Doxorubicin toxicity.
    Legha SS; Benjamin RS
    Ann Intern Med; 1981 Oct; 95(4):520-1. PubMed ID: 7283314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.